Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19

The Japanese Respiratory Society (JRS) pneumonia guidelines recommend simple predictive rules, the A-DROP scoring system, for assessment of the severity of community-acquired pneumonia (CAP) and nursing and healthcare-associated pneumonia (NHCAP). We evaluated whether the A-DROP system can be adapte...

Full description

Saved in:
Bibliographic Details
Published in:Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2023-05, Vol.29 (5), p.437-442
Main Authors: Miyashita, Naoyuki, Nakamori, Yasushi, Ogata, Makoto, Fukuda, Naoki, Yamura, Akihisa, Ishiura, Yoshihisa
Format: Article
Language:English
Subjects:
A-DROP
Community-Acquired Infections - drug therapy
Community-acquired pneumonia
COVID-19
Cross Infection - drug therapy
Healthcare-Associated Pneumonia
Humans
Nursing and healthcare-associated pneumonia
Pneumonia - diagnosis
Pneumonia severity
Retrospective Studies
SARS-CoV-2
Severity of Illness Index
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c424t-76bdebaba28a542235131632a06128531bdfc62e8f0c366884c31e288e6616b63
cites cdi_FETCH-LOGICAL-c424t-76bdebaba28a542235131632a06128531bdfc62e8f0c366884c31e288e6616b63
container_end_page 442
container_issue 5
container_start_page 437
container_title Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
container_volume 29
creator Miyashita, Naoyuki
Nakamori, Yasushi
Ogata, Makoto
Fukuda, Naoki
Yamura, Akihisa
Ishiura, Yoshihisa
description The Japanese Respiratory Society (JRS) pneumonia guidelines recommend simple predictive rules, the A-DROP scoring system, for assessment of the severity of community-acquired pneumonia (CAP) and nursing and healthcare-associated pneumonia (NHCAP). We evaluated whether the A-DROP system can be adapted for assessment of the severity of coronavirus disease 2019 (COVID-19) pneumonia. Data from 1141 patients with COVID-19 pneumonia were analyzed, comprising 502 patients observed in the 1st to 3rd wave period, 338 patients in the 4th wave and 301 patients in the 5th wave in Japan. The mortality rate and mechanical ventilation rate were 0% and 1.4% in patients classified with mild disease (A-DROP score, 0 point), 3.2% and 46.7% in those with moderate disease (1 or 2 points), 20.8% and 78.3% with severe disease (3 points), and 55.0% and 100% with extremely severe disease (4 or 5 points), indicating an increase in the mortality and mechanical ventilation rates in accordance with severity (Cochran–Armitage trend test; p =
doi_str_mv 10.1016/j.jiac.2022.12.007
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2758354435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1341321X22003300</els_id><sourcerecordid>2758354435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-76bdebaba28a542235131632a06128531bdfc62e8f0c366884c31e288e6616b63</originalsourceid><addsrcrecordid>eNp9kD1vFDEQhi0EIiHwByiQS5pd_LVeR6KJLgQiRUpDIjrL653lfLq1Lx5vpHT8dHy5QLpUMxo97yvNQ8hHzlrOuP6yaTfB-VYwIVouWsb6V-SYK9k3fW_Y67pLxRsp-K8j8g5xwxjvO2PekiOpO90zdXpM_pwhAuIMsdA00bIGuouwzCkGRxHuIYfyQNGnDDRE6tM8L7GeGufvlpBhpC6ONC4ZQ_z9uK_BbcvauwyNQ0w-uFKp59JxAVoSXV3fXp43_PQ9eTO5LcKHp3lCbi6-_Vz9aK6uv1-uzq4ar4QqTa-HEQY3OGFcp4SQHZdcS-GY5sJ0kg_j5LUAMzEvtTZGeclBGANacz1oeUI-H3p3Od0tgMXOAT1sty5CWtCKqkZ2SsmuouKA-pwQM0x2l8Ps8oPlzO7N243dm7d785YLW83X0Ken_mWYYfwf-ae6Al8PANQv7wNkiz5A9DBWjb7YMYWX-v8C0NCVgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2758354435</pqid></control><display><type>article</type><title>Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto ; Fukuda, Naoki ; Yamura, Akihisa ; Ishiura, Yoshihisa</creator><creatorcontrib>Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto ; Fukuda, Naoki ; Yamura, Akihisa ; Ishiura, Yoshihisa</creatorcontrib><description>The Japanese Respiratory Society (JRS) pneumonia guidelines recommend simple predictive rules, the A-DROP scoring system, for assessment of the severity of community-acquired pneumonia (CAP) and nursing and healthcare-associated pneumonia (NHCAP). We evaluated whether the A-DROP system can be adapted for assessment of the severity of coronavirus disease 2019 (COVID-19) pneumonia. Data from 1141 patients with COVID-19 pneumonia were analyzed, comprising 502 patients observed in the 1st to 3rd wave period, 338 patients in the 4th wave and 301 patients in the 5th wave in Japan. The mortality rate and mechanical ventilation rate were 0% and 1.4% in patients classified with mild disease (A-DROP score, 0 point), 3.2% and 46.7% in those with moderate disease (1 or 2 points), 20.8% and 78.3% with severe disease (3 points), and 55.0% and 100% with extremely severe disease (4 or 5 points), indicating an increase in the mortality and mechanical ventilation rates in accordance with severity (Cochran–Armitage trend test; p = &lt;0.001). This significant relationship between the severity in the A-DROP scoring system and either the mortality rate or mechanical ventilation rate was observed in patients with COVID-19 CAP and NHCAP. In each of the five COVID-19 waves, the same significant relationship was observed. The mortality rate and mechanical ventilation rate in patients with COVID-19 pneumonia increased depending on severity classified according to the A-DROP scoring system. Our results suggest that the A-DROP scoring system can be adapted for the assessment of severity of COVID-19 CAP and NHCAP.</description><identifier>ISSN: 1341-321X</identifier><identifier>EISSN: 1437-7780</identifier><identifier>DOI: 10.1016/j.jiac.2022.12.007</identifier><identifier>PMID: 36567049</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>A-DROP ; Community-Acquired Infections - drug therapy ; Community-acquired pneumonia ; COVID-19 ; Cross Infection - drug therapy ; Healthcare-Associated Pneumonia ; Humans ; Nursing and healthcare-associated pneumonia ; Pneumonia - diagnosis ; Pneumonia severity ; Retrospective Studies ; SARS-CoV-2 ; Severity of Illness Index</subject><ispartof>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023-05, Vol.29 (5), p.437-442</ispartof><rights>2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control</rights><rights>Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-76bdebaba28a542235131632a06128531bdfc62e8f0c366884c31e288e6616b63</citedby><cites>FETCH-LOGICAL-c424t-76bdebaba28a542235131632a06128531bdfc62e8f0c366884c31e288e6616b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36567049$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miyashita, Naoyuki</creatorcontrib><creatorcontrib>Nakamori, Yasushi</creatorcontrib><creatorcontrib>Ogata, Makoto</creatorcontrib><creatorcontrib>Fukuda, Naoki</creatorcontrib><creatorcontrib>Yamura, Akihisa</creatorcontrib><creatorcontrib>Ishiura, Yoshihisa</creatorcontrib><title>Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19</title><title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</title><addtitle>J Infect Chemother</addtitle><description>The Japanese Respiratory Society (JRS) pneumonia guidelines recommend simple predictive rules, the A-DROP scoring system, for assessment of the severity of community-acquired pneumonia (CAP) and nursing and healthcare-associated pneumonia (NHCAP). We evaluated whether the A-DROP system can be adapted for assessment of the severity of coronavirus disease 2019 (COVID-19) pneumonia. Data from 1141 patients with COVID-19 pneumonia were analyzed, comprising 502 patients observed in the 1st to 3rd wave period, 338 patients in the 4th wave and 301 patients in the 5th wave in Japan. The mortality rate and mechanical ventilation rate were 0% and 1.4% in patients classified with mild disease (A-DROP score, 0 point), 3.2% and 46.7% in those with moderate disease (1 or 2 points), 20.8% and 78.3% with severe disease (3 points), and 55.0% and 100% with extremely severe disease (4 or 5 points), indicating an increase in the mortality and mechanical ventilation rates in accordance with severity (Cochran–Armitage trend test; p = &lt;0.001). This significant relationship between the severity in the A-DROP scoring system and either the mortality rate or mechanical ventilation rate was observed in patients with COVID-19 CAP and NHCAP. In each of the five COVID-19 waves, the same significant relationship was observed. The mortality rate and mechanical ventilation rate in patients with COVID-19 pneumonia increased depending on severity classified according to the A-DROP scoring system. Our results suggest that the A-DROP scoring system can be adapted for the assessment of severity of COVID-19 CAP and NHCAP.</description><subject>A-DROP</subject><subject>Community-Acquired Infections - drug therapy</subject><subject>Community-acquired pneumonia</subject><subject>COVID-19</subject><subject>Cross Infection - drug therapy</subject><subject>Healthcare-Associated Pneumonia</subject><subject>Humans</subject><subject>Nursing and healthcare-associated pneumonia</subject><subject>Pneumonia - diagnosis</subject><subject>Pneumonia severity</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><subject>Severity of Illness Index</subject><issn>1341-321X</issn><issn>1437-7780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kD1vFDEQhi0EIiHwByiQS5pd_LVeR6KJLgQiRUpDIjrL653lfLq1Lx5vpHT8dHy5QLpUMxo97yvNQ8hHzlrOuP6yaTfB-VYwIVouWsb6V-SYK9k3fW_Y67pLxRsp-K8j8g5xwxjvO2PekiOpO90zdXpM_pwhAuIMsdA00bIGuouwzCkGRxHuIYfyQNGnDDRE6tM8L7GeGufvlpBhpC6ONC4ZQ_z9uK_BbcvauwyNQ0w-uFKp59JxAVoSXV3fXp43_PQ9eTO5LcKHp3lCbi6-_Vz9aK6uv1-uzq4ar4QqTa-HEQY3OGFcp4SQHZdcS-GY5sJ0kg_j5LUAMzEvtTZGeclBGANacz1oeUI-H3p3Od0tgMXOAT1sty5CWtCKqkZ2SsmuouKA-pwQM0x2l8Ps8oPlzO7N243dm7d785YLW83X0Ken_mWYYfwf-ae6Al8PANQv7wNkiz5A9DBWjb7YMYWX-v8C0NCVgA</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Miyashita, Naoyuki</creator><creator>Nakamori, Yasushi</creator><creator>Ogata, Makoto</creator><creator>Fukuda, Naoki</creator><creator>Yamura, Akihisa</creator><creator>Ishiura, Yoshihisa</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202305</creationdate><title>Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19</title><author>Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto ; Fukuda, Naoki ; Yamura, Akihisa ; Ishiura, Yoshihisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-76bdebaba28a542235131632a06128531bdfc62e8f0c366884c31e288e6616b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>A-DROP</topic><topic>Community-Acquired Infections - drug therapy</topic><topic>Community-acquired pneumonia</topic><topic>COVID-19</topic><topic>Cross Infection - drug therapy</topic><topic>Healthcare-Associated Pneumonia</topic><topic>Humans</topic><topic>Nursing and healthcare-associated pneumonia</topic><topic>Pneumonia - diagnosis</topic><topic>Pneumonia severity</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miyashita, Naoyuki</creatorcontrib><creatorcontrib>Nakamori, Yasushi</creatorcontrib><creatorcontrib>Ogata, Makoto</creatorcontrib><creatorcontrib>Fukuda, Naoki</creatorcontrib><creatorcontrib>Yamura, Akihisa</creatorcontrib><creatorcontrib>Ishiura, Yoshihisa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miyashita, Naoyuki</au><au>Nakamori, Yasushi</au><au>Ogata, Makoto</au><au>Fukuda, Naoki</au><au>Yamura, Akihisa</au><au>Ishiura, Yoshihisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19</atitle><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle><addtitle>J Infect Chemother</addtitle><date>2023-05</date><risdate>2023</risdate><volume>29</volume><issue>5</issue><spage>437</spage><epage>442</epage><pages>437-442</pages><issn>1341-321X</issn><eissn>1437-7780</eissn><abstract>The Japanese Respiratory Society (JRS) pneumonia guidelines recommend simple predictive rules, the A-DROP scoring system, for assessment of the severity of community-acquired pneumonia (CAP) and nursing and healthcare-associated pneumonia (NHCAP). We evaluated whether the A-DROP system can be adapted for assessment of the severity of coronavirus disease 2019 (COVID-19) pneumonia. Data from 1141 patients with COVID-19 pneumonia were analyzed, comprising 502 patients observed in the 1st to 3rd wave period, 338 patients in the 4th wave and 301 patients in the 5th wave in Japan. The mortality rate and mechanical ventilation rate were 0% and 1.4% in patients classified with mild disease (A-DROP score, 0 point), 3.2% and 46.7% in those with moderate disease (1 or 2 points), 20.8% and 78.3% with severe disease (3 points), and 55.0% and 100% with extremely severe disease (4 or 5 points), indicating an increase in the mortality and mechanical ventilation rates in accordance with severity (Cochran–Armitage trend test; p = &lt;0.001). This significant relationship between the severity in the A-DROP scoring system and either the mortality rate or mechanical ventilation rate was observed in patients with COVID-19 CAP and NHCAP. In each of the five COVID-19 waves, the same significant relationship was observed. The mortality rate and mechanical ventilation rate in patients with COVID-19 pneumonia increased depending on severity classified according to the A-DROP scoring system. Our results suggest that the A-DROP scoring system can be adapted for the assessment of severity of COVID-19 CAP and NHCAP.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>36567049</pmid><doi>10.1016/j.jiac.2022.12.007</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1341-321X
ispartof Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023-05, Vol.29 (5), p.437-442
issn 1341-321X
1437-7780
language eng
recordid cdi_proquest_miscellaneous_2758354435
source ScienceDirect Freedom Collection 2022-2024
subjects A-DROP
Community-Acquired Infections - drug therapy
Community-acquired pneumonia
COVID-19
Cross Infection - drug therapy
Healthcare-Associated Pneumonia
Humans
Nursing and healthcare-associated pneumonia
Pneumonia - diagnosis
Pneumonia severity
Retrospective Studies
SARS-CoV-2
Severity of Illness Index
title Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A00%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20the%20pneumonia%20severity%20score%20in%20community-acquired%20and%20nursing%20and%20healthcare-associated%20pneumonia%20due%20to%20COVID-19&rft.jtitle=Journal%20of%20infection%20and%20chemotherapy%20:%20official%20journal%20of%20the%20Japan%20Society%20of%20Chemotherapy&rft.au=Miyashita,%20Naoyuki&rft.date=2023-05&rft.volume=29&rft.issue=5&rft.spage=437&rft.epage=442&rft.pages=437-442&rft.issn=1341-321X&rft.eissn=1437-7780&rft_id=info:doi/10.1016/j.jiac.2022.12.007&rft_dat=%3Cproquest_cross%3E2758354435%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c424t-76bdebaba28a542235131632a06128531bdfc62e8f0c366884c31e288e6616b63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2758354435&rft_id=info:pmid/36567049&rfr_iscdi=true